Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $12.9M | $11.5M | $9.4M | $3.6M |
| Gross profit | $3.4M | $3.2M | $3.2M | $1.7M |
| Research & development | $302,118 | $28,981 | $122,441 | $60,883 |
| Operating expenses | $3.5M | $741,469 | $1.0M | $1.2M |
| Operating income | −$138,576 | $2.5M | $2.2M | $498,522 |
| EBITDAderived | −$68,079 | $2.5M | $2.2M | $518,049 |
| Net income | −$322,202 | $2.1M | $1.9M | $372,435 |
| Basic EPSper diluted share | -$0.02 | $0.14 | $0.12 | $0.02 |
| Diluted EPSper diluted share | -$0.02 | $0.14 | $0.12 | $0.02 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 4, 2026Form 4 | HRT FINANCIAL LPTenPercentOwner | SellCommon Stock | 128.7K | $5.36 | $689.8K | 59.7K |
| Jun 3, 2026Form 4 | HRT FINANCIAL LPTenPercentOwner | BuyCommon Stock | 65.1K | $4.71 | $306.5K | 188.4K |